Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Defiance Introduces 2X Daily Leveraged ETF Tracking Moderna Shares: Defiance launched the Daily Target 2X Long MRNA ETF, seeking to deliver 200% of Moderna share movements on a daily basis through a liquid, exchange-traded vehicle. The fund resets every trading day and targets short-term tactical exposure for sophisticated investors due to potential volatility and performance divergence over time.
| Metric | Value |
|---|---|
| Price | $27.10 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 171.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
MRNX analyst coverage data. Average price target: $0.00.